• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
Are we prescribing antibiotics wrong?

Are we prescribing antibiotics wrong?

The message has always been clear: make sure to finish your full course of antibiotics. Or else? Risk the development of antibiotic resistance - a...
Outsourcing Clinical Trials Outside of the US

Outsourcing Clinical Trials Outside of the US

Outsourcing clinical trials has been a subject of both controversy and relevance in the pharmaceutical community. It is an important part of drug...
Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma

Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma

Last year was a banner year for new drugs, with 46 new molecular entities approved by the FDA, compared to 22 in 2016. 2017 also saw the approval of...
Two-dimensional liquid chromatography with multiple heart-cutting

Two-dimensional liquid chromatography with multiple heart-cutting

Two-dimensional liquid chromatography (2D-LC) has obtained increasing focus over the past two decades. At LEO Pharma, we continuously evaluate new...
Understanding Pharmaceutical Logistics Validation in a Dynamic Environment

Understanding Pharmaceutical Logistics Validation in a Dynamic Environment

Applying validation standards to bio/pharmaceutical logistics, the science of transporting bio/analytical, clinical and manufactured product, is an...
Are we prescribing antibiotics wrong?
Are we prescribing antibiotics wrong?
Outsourcing Clinical Trials Outside of the US
Outsourcing Clinical Trials Outside of the US
Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma
Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma
Two-dimensional liquid chromatography with multiple heart-cutting
Two-dimensional liquid chromatography with multiple heart-cutting
Understanding Pharmaceutical Logistics Validation in a Dynamic Environment
Understanding Pharmaceutical Logistics Validation in a Dynamic Environment

Latest White Papers

  • Random

Latest News

  • Title
  • Most Views
  • Recently Added
  • Ordering
  • Random
Load More
Load More
VV116

The drug, called VV116, is a derivative of Gilead Sciences's COVID drug Remdesivir and was approved ...

Q3 Medical Devices Limited

Journal of Endovascular Therapy, 2022 (Impact factor 3.487 source Sage Journals) with title "Stents ...

Chemistry Laboratory Robots Market

This report studies the Chemistry Laboratory Robots Market with many aspects of the industry like ...

Urologists analyze stewardship of opioid and antibiotic prescribing

Recent studies about the reduction in narcotics or antibiotics prescriptions for postoperative pain ...

Load More
Load More
Load More

Latest Updates

Factor Bioscience Inc., a Cambridge-based biotechnology company focused on developing mRNA and cell-engineering technologies, its participation in the American Society of Gene & Cell Therapy ...

Factor Bioscience Inc., a Cambridge-based biotechnology company focused on developing mRNA and cell-engineering technologies, its participation in the American Society of Gene & Cell Therapy (ASGCT).

25th Annual Meeting to be held in Washington, D.C. from May 16-19, 2022, at which Factor ...

PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TPEx:6446), a global biopharmaceutical innovator leveraging deep expertise and proven scientific principles to deliver new ...

PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TPEx:6446), a global biopharmaceutical innovator leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, the appointment of Meredith Manning to President of the ...

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, it dosed the first set of volunteers in an open-label study of AKS-452, its protein subunit COVID-19 vaccine, as a ...

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, it dosed the first set of volunteers in an open-label study of AKS-452, its protein subunit COVID-19 vaccine, as a booster.

The Phase II booster study is designed to investigate the response of the immune ...

BMG LABTECH introduced the new VANTAstar™ microplate reader, further expanding its range of high-quality, made-in-Germany instruments.

The latest addition to the BMG LABTECH portfolio, the ...

BMG LABTECH introduced the new VANTAstar™ microplate reader, further expanding its range of high-quality, made-in-Germany instruments.

The latest addition to the BMG LABTECH portfolio, the VANTAstar was conceived for ease-of-use and flexibility for a wide range of applications in basic research ...

At the ISMRM 2022 conference, Bruker the launch of innovative 7 Tesla and 9.4 Tesla conduction-cooled Maxwell magnets for its market-leading preclinical magnetic resonance imaging (MRI) systems ...

At the ISMRM 2022 conference, Bruker the launch of innovative 7 Tesla and 9.4 Tesla conduction-cooled Maxwell magnets for its market-leading preclinical magnetic resonance imaging (MRI) systems portfolio.

Following the success of its BioSpec® Maxwell 3 Tesla model, the new range of Maxwell 7 ...

STORM Therapeutics, the biotechnology company focused on the discovery of small molecule therapies targeting RNA epigenetic mechanisms.

That it has been awarded a Biomedical Catalyst grant by ...

STORM Therapeutics, the biotechnology company focused on the discovery of small molecule therapies targeting RNA epigenetic mechanisms.

That it has been awarded a Biomedical Catalyst grant by Innovate UK to research and develop new drugs directed against a unique SARS-CoV2 protein utilizing ...